News Conference News AHA 2022 First-line Ablation Reduces AF Progression, Boosts Quality of Life Todd Neale November 07, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT Todd Neale October 17, 2022
Presentation TCT 2022 PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy Presenter: Usman Baber September 18, 2022
News Daily News VITAL Rhythm Data May Flip the Script on AF Screening in Women L.A. McKeown September 08, 2022
News Daily News Early Rhythm Control Also May Help Lower-Risk AF Patients Todd Neale September 07, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Daily News Postoperative AF ‘Not Benign,’ Just As Likely to Cause Stroke Yael L. Maxwell July 29, 2022
News Daily News Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes Todd Neale July 04, 2022
News Conference News HRS 2022 Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era Todd Neale May 02, 2022
News Conference News HRS 2022 Intensive BP Control May Stave Off LV Conduction Disease: SPRINT Todd Neale May 02, 2022
News Conference News HRS 2022 Ablation May Beat Drugs for Reducing Dementia Risk in AF Patients Todd Neale April 30, 2022
News Conference News HRS 2022 Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients Todd Neale April 29, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking Todd Neale January 25, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Stimulants Linked to Early Risk of CV Events in Elderly Michael O'Riordan October 25, 2021